Ekso Bionics Holdings Inc
NASDAQ:EKSO

Watchlist Manager
Ekso Bionics Holdings Inc Logo
Ekso Bionics Holdings Inc
NASDAQ:EKSO
Watchlist
Price: 9.53 USD 11.46% Market Closed
Market Cap: 32.3m USD

Ekso Bionics Holdings Inc
Cash

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Ekso Bionics Holdings Inc
Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
Ekso Bionics Holdings Inc
NASDAQ:EKSO
Cash
$2.7m
CAGR 3-Years
-55%
CAGR 5-Years
-28%
CAGR 10-Years
-13%
Becton Dickinson and Co
NYSE:BDX
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ekso Bionics Holdings Inc
Glance View

Market Cap
32.3m USD
Industry
Health Care

Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company is headquartered in Richmond California, California and currently employs 45 full-time employees. The company went IPO on 2013-04-10. The Company’s exoskeleton technology serves multiple markets and can be utilized both by able-bodied users and persons with physical disabilities. The firm operates in two segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform repetitive work. Its products include EksoNR and EksoUE. EksoNR is a rehabilitation device that assists physical therapists and physicians to treat patients who have suffered an acquired brain injury, stroke or spinal cord injury. EksoUE is a wearable upper body exoskeleton that assists patients with a broad range of upper extremity impairments.

EKSO Intrinsic Value
20.01 USD
Undervaluation 52%
Intrinsic Value
Price

See Also

What is Ekso Bionics Holdings Inc's Cash?
Cash
2.7m USD

Based on the financial report for Sep 30, 2025, Ekso Bionics Holdings Inc's Cash amounts to 2.7m USD.

What is Ekso Bionics Holdings Inc's Cash growth rate?
Cash CAGR 10Y
-13%

Over the last year, the Cash growth was -67%. The average annual Cash growth rates for Ekso Bionics Holdings Inc have been -55% over the past three years , -28% over the past five years , and -13% over the past ten years .

Back to Top